Active dimer of Epratuzumab provides insight into the complex nature of an antibody aggregate.
Remmele RL Jr, Callahan WJ, Krishnan S, Zhou L, Bondarenko PV, Nichols AC, Kleemann GR, Pipes GD, Park S, Fodor S, Kras E, Brems DN.
Remmele RL Jr, et al. Among authors: krishnan s.
J Pharm Sci. 2006 Jan;95(1):126-45. doi: 10.1002/jps.20515.
J Pharm Sci. 2006.
PMID: 16315222